Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nicotine effects on brain function and functional connectivity in schizophrenia.

Leslie K Jacobsen1, D Cyril D'Souza, W Einar Mencl

  • 1Department of Psychiatry, Yale University School of Medicine, 100 York Street #28, West Haven, CT 06511, USA.

Biological Psychiatry
|March 31, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Profiling neuronal methylome and hydroxymethylome of opioid use disorder in the human orbitofrontal cortex.

Nature communications·2023
Same author

Single-Nucleus Transcriptome Profiling of Dorsolateral Prefrontal Cortex: Mechanistic Roles for Neuronal Gene Expression, Including the 17q21.31 Locus, in PTSD Stress Response.

The American journal of psychiatry·2023
Same author

Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2023
Same author

DSM-5 criterion-a-based trauma types in service members and veterans seeking treatment for posttraumatic stress disorder.

Psychological trauma : theory, research, practice and policy·2023
Same author

Cross-Species Convergence of Brain Transcriptomic and Epigenomic Findings in Posttraumatic Stress Disorder: A Systematic Review.

Complex psychiatry·2023
Same author

Long term structural and functional neural changes following a single infusion of Ketamine in PTSD.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2023

Nicotine may improve cognitive function in schizophrenia patients by enhancing brain activity and connectivity. This study investigated nicotine

Area of Science:

  • Neuroscience
  • Psychiatry
  • Cognitive Science

Background:

  • Nicotine in tobacco smoke is known to enhance cognitive functions across various domains.
  • High smoking prevalence in schizophrenia patients suggests a potential self-medication strategy for cognitive deficits.
  • Understanding nicotine's effects on brain function is crucial for developing targeted interventions.

Purpose of the Study:

  • To investigate whether nicotine administration improves cognitive function in schizophrenia patients.
  • To determine if nicotine enhances cognitive performance by increasing brain region activation or functional connectivity.

Main Methods:

  • Functional magnetic resonance imaging (fMRI) was used to scan 13 smokers with schizophrenia and 13 healthy smokers.
  • Subjects underwent fMRI scans twice: once with a nicotine patch and once with a placebo patch.

Related Experiment Videos

  • Participants performed an n-back task assessing working memory and selective attention under varying cognitive loads.

    • Main Results:

    • Nicotine improved performance on a demanding cognitive task (dichotic 2-back) in schizophrenia patients, while impairing controls.
    • Nicotine enhanced activation in brain networks including the anterior cingulate cortex and bilateral thalamus.
    • Nicotine modulated thalamocortical functional connectivity more significantly in schizophrenia patients than in controls.

    Conclusions:

    • Nicotine may enhance cognitive performance in schizophrenia by boosting neural activation and functional connectivity.
    • These findings suggest a neurobiological mechanism for nicotine's cognitive-enhancing effects in schizophrenia.
    • Targeting these brain mechanisms could lead to novel therapeutic strategies for cognitive dysfunction in schizophrenia.